FVIM
ENZ

Fort Vancouver Investment Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Fort Vancouver Investment Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,599
Closed -$592 – 61
2025
Q1 		$592 Buy
+1,599
New +$883 ﹤0.01% 53

Other funds holding ENZ

OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

Fort Vancouver Investment Management's ENZ Position: Q2 2025 in Review

Fort Vancouver Investment Management sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 1,599 shares — an estimated $592 sold.

Fort Vancouver Investment Management first reported a position in ENZ in Q1 2025 and held it in 1 quarter. The position peaked at $592 in Q1 2025. 7 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Fort Vancouver Investment Management reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Fort Vancouver Investment Management sold 1,599 Enzo Biochem, Inc. shares in Q2 2025, an estimated $592.
  • Fort Vancouver Investment Management first reported a position in Enzo Biochem, Inc. in Q1 2025 and held it in 1 quarter.
  • Fort Vancouver Investment Management's Enzo Biochem, Inc. position peaked at $592 in Q1 2025.
  • 7 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Fort Vancouver Investment Management's 13F filing for Q2 2025, filed 1 Aug 2025.